Organovo Holdings Inc - ESG Rating & Company Profile powered by AI
This article includes a questions and answers table on Organovo Holdings Inc. The webpage is a free ESG analysis for Organovo Holdings Inc. Check the end of the page for potential risks for Organovo Holdings Inc based on sector, geography and size.
Organovo Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Organovo Holdings Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Organovo Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Organovo Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Organovo Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes Organovo Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Organovo Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Organovo Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Organovo Holdings Inc offer flexible work?
Sign up for free to unlockDoes Organovo Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Organovo Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Organovo Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes Organovo Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Organovo Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Organovo Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Organovo Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Organovo Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Organovo Holdings Inc disclose water use targets?
Sign up for free to unlockDoes Organovo Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Organovo Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes Organovo Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Organovo Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Organovo Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Organovo Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes Organovo Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Organovo Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Organovo Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Organovo Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Organovo Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Organovo Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Organovo Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Organovo Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Organovo Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes Organovo Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes Organovo Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Organovo Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes Organovo Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Organovo Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Organovo Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.